BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2014

Dec 12, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-12-10

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-10	Common Stock	M	2000	$12.99	Acquired	45195	Indirect
2014-12-10	Common Stock	S	2000	$95.00	Disposed	43195	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-12-10	Stock Option (right to buy Common Stock)	$12.99	M	2000	Disposed	2016-05-10	Common Stock (2000)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	229157	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy Common Stock)	$12.99	2016-05-10	Common Stock (10000)	10000	Indirect
Stock Option (right to buy Common Stock)	$12.99	2016-05-10	Common Stock (10000)	10000	Indirect
Stock Option (right to buy Common Stock)	$12.99	2016-05-10	Common Stock (10000)	10000	Indirect
Stock Option (right to buy Common Stock)	$12.99	2016-05-10	Common Stock (10000)	10000	Indirect
Stock Option (right to buy Common Stock)	$12.99	2016-05-10	Common Stock (20000)	20000	Indirect

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed August 20, 2014

F2: The reporting person an his spouse act as trustees for the Bienaime Family Trust

F3: All shares sold at same price

F4: Original option grant vests 6/48ths on November 11, 2006, and 1/48th on the 11th of every month thereafter.

F5: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.

F6: The reporting person's spouse is the trustee of each child's trust.